» Articles » PMID: 6722122

Interaction of Tubulin with Bifunctional Colchicine Analogues: an Equilibrium Study

Overview
Journal Biochemistry
Specialty Biochemistry
Date 1984 Apr 10
PMID 6722122
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The interaction of tubulin with simple analogues of colchicine that contain both its tropolone and trimethoxyphenyl rings has been characterized, and the results were analyzed in terms of the simple bifunctional ligand model developed for the binding of colchicine [ Andreu , J. M., & Timasheff , S. N. (1982) Biochemistry 21, 534-543] on the basis of interactions of tubulin with single-ring analogues. The compound 2-methoxy-5-(2,3,4-trimethoxyphenyl)-2,4,6- cycloheptatrien -1-one has been found to bind reversibly to 0.86 +/- 0.06 site of purified calf brain tubulin with an equilibrium constant of (4.9 +/- 0.3) X 10(5) M-1 (25 degrees C), delta H degrees app = -1.6 +/- 0.7 kcal mol-1, and delta S degrees app = 20.5 +/- 2.5 eu. The binding appears specific for the colchicine site. The closely related compound 2-methoxy-5-[[3-(3,4,5-trimethoxyphenyl)-propionyl]amino] -2,4,6- cycloheptatrien -1-one interacts weakly with tubulin. Binding of the first analogue is accompanied by ligand fluorescence appearance, quenching of protein fluorescence, perturbation of the far-ultraviolet circular dichroism of tubulin, and induction of the tubulin GTPase activity, similarly to colchicine binding. Substoichiometric concentrations of the analogue inhibit microtubule assembly in vitro. Excess analogue concentration under microtubule-promoting conditions induces an abnormal cooperative polymerization of tubulin, similar to that of the tubulin-colchicine complex.

Citing Articles

Myotoxin-3 from the Pacific Rattlesnake Venom Is a New Microtubule-Targeting Agent.

Gonzalez Garcia M, Radix C, Villard C, Breuzard G, Mansuelle P, Barbier P Molecules. 2022; 27(23).

PMID: 36500334 PMC: 9739105. DOI: 10.3390/molecules27238241.


-alkylisatin-based microtubule destabilizers bind to the colchicine site on tubulin and retain efficacy in drug resistant acute lymphoblastic leukemia cell lines with less in vitro neurotoxicity.

Keenan B, Finol-Urdaneta R, Hope A, Bremner J, Kavallaris M, Lucena-Agell D Cancer Cell Int. 2020; 20:170.

PMID: 32467666 PMC: 7229617. DOI: 10.1186/s12935-020-01251-6.


Identification of pyrrolopyrimidine derivative PP-13 as a novel microtubule-destabilizing agent with promising anticancer properties.

Gilson P, Josa-Prado F, Beauvineau C, Naud-Martin D, Vanwonterghem L, Mahuteau-Betzer F Sci Rep. 2017; 7(1):10209.

PMID: 28860487 PMC: 5579042. DOI: 10.1038/s41598-017-09491-9.


Comparison of carbon-sulfur and carbon-amine bond in therapeutic drug: 4β-S-aromatic heterocyclic podophyllum derivatives display antitumor activity.

Li J, Zhao W, Zhou C, Zhang Y, Li H, Tang Y Sci Rep. 2015; 5:14814.

PMID: 26443888 PMC: 4595834. DOI: 10.1038/srep14814.


Tubulin structure-based drug design for the development of novel 4β-sulfur-substituted podophyllum tubulin inhibitors with anti-tumor activity.

Zhao W, Bai J, Li H, Chen T, Tang Y Sci Rep. 2015; 5:10172.

PMID: 25959922 PMC: 4426677. DOI: 10.1038/srep10172.